Targeting herpetic keratitis by gene therapy.
Hossein Mostafa Elbadawy1, Marine Gailledrat, Carole Desseaux
1The Veneto Eye Bank Foundation, Via Paccagnella 11, Padiglione Giovanni Rama, Zelarino, 30174 Venice, Italy.
Journal of Ophthalmology
|January 18, 2013
Summary
Ocular gene therapy offers a promising alternative to traditional treatments for herpetic keratitis. This approach targets the herpes simplex virus 1 (HSV-1) to prevent blindness and inflammation associated with ocular infections.
Area of Science:
- Ophthalmology
- Gene Therapy
- Virology
Background:
- Herpetic keratitis, caused by herpes simplex virus 1 (HSV-1), is a significant cause of blindness with frequent recurrences.
- Cornea transplantation may not be the ideal long-term solution due to disease recurrence.
Purpose of the Study:
- To review the current landscape of ocular gene therapy research for herpetic keratitis.
- To explore various gene therapy strategies, including viral and nonviral vectors, gene expression modulation, and delivery methods.
Main Methods:
- Literature screening of gene therapy approaches for herpetic keratitis.
- Analysis of candidate gene targets and therapeutic strategies.
- Comparison of gene therapy with antiviral treatments for HSV-1 ocular infections.
Main Results:
- Gene therapy research is exploring transgene expression, gene replacement, silencing, and clipping for herpetic keratitis.
- Various viral and nonviral vectors are being investigated for ocular gene delivery.
- Gene therapy strategies aim to address long-term HSV-1 infection signs like inflammation and neovascularization.
Conclusions:
- Ocular gene therapy presents innovative physiological and pharmaceutical solutions for managing herpetic keratitis.
- Successful gene therapy could offer a more effective long-term strategy against HSV-1 ocular infections compared to current treatments.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...